ANI Pharmaceuticals, Inc. | Company Profile - Revenue, Headcount, Tech Stack, Contacts

ANI Pharmaceuticals, Inc. is a U.S.-focused biopharmaceutical company dedicated to developing, manufacturing, and marketing high-quality branded and generic prescription pharmaceuticals. Founded in the 1930s, the organization has evolved significantly, incorporating in 2001 and entering the NASDAQ exchange through a pivotal reverse merger in 2013. Its mission of "Serving Patients, Improving Lives" reflects a strong commitment to addressing unmet medical needs through innovative therapeutics and consistent, reliable supply.

The company operates across Rare Disease, Generics, and Established Brands business segments. The Rare Disease segment develops novel products for areas such as ophthalmology and neurology, while the Generics division uses extensive R&D expertise to expand a portfolio of generic medications. The Established Brands group includes key therapies like Purified Cortrophin Gel, and the company also provides contract development and manufacturing services to the wider pharmaceutical sector, driving revenue and expanding operational capacity.